Header Logo

Connection

Laura Bogart to Anti-HIV Agents

Back to Details
This is a "connection" page, showing publications Laura Bogart has written about Anti-HIV Agents.
Laura Bogart
Connection Strength
4.976
Anti-HIV Agents
  1. Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes. AIDS Behav. 2024 Oct; 28(10):3512-3524.
    View in: PubMed
    Score: 0.788
  2. HIV-Related Mistrust?(or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United States. AIDS Behav. 2020 Oct; 24(10):2927-2934.
    View in: PubMed
    Score: 0.606
  3. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV. J Acquir Immune Defic Syndr. 2010 Apr; 53(5):648-55.
    View in: PubMed
    Score: 0.293
  4. Applying implementation science frameworks to understand why fisherfolk continue or discontinue pre-exposure prophylaxis for HIV prevention in Uganda: a qualitative analysis. BMJ Glob Health. 2025 Jan 22; 10(1).
    View in: PubMed
    Score: 0.204
  5. A Qualitative Assessment of South Africa's Central Chronic Medication Dispensing and Distribution Program for Differentiated Antiretroviral Therapy Delivery in Umlazi Township, South Africa: Client Perspectives after 12 Months of Participation. AIDS Behav. 2025 Feb; 29(2):673-683.
    View in: PubMed
    Score: 0.201
  6. Pilot Test of Mopati, a Multi-Level Adherence Intervention for People Living with HIV and Their Treatment Partners in Botswana. Int J Behav Med. 2024 Oct; 31(5):787-798.
    View in: PubMed
    Score: 0.188
  7. Unmet Social Needs are Associated with Lower Adherence to Antiretroviral Therapy (ART) Medication Among a Sample of Black People Living with HIV (PLHIV). AIDS Behav. 2023 Nov; 27(11):3651-3660.
    View in: PubMed
    Score: 0.182
  8. Understanding Repeat Positive HIV Testing in South Africa Under Changing Treatment Guidelines. AIDS Behav. 2022 May; 26(5):1366-1376.
    View in: PubMed
    Score: 0.163
  9. Multilevel Barriers to HIV?PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California. AIDS Behav. 2021 Jul; 25(7):2301-2315.
    View in: PubMed
    Score: 0.155
  10. Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making. 2001 Jan-Feb; 21(1):28-36.
    View in: PubMed
    Score: 0.154
  11. The Treatment Ambassador Program: A Highly Acceptable and Feasible Community-Based Peer Intervention for South Africans Living with HIV Who Delay or Discontinue Antiretroviral Therapy. AIDS Behav. 2021 Apr; 25(4):1129-1143.
    View in: PubMed
    Score: 0.152
  12. Area-level HIV risk and socioeconomic factors associated with willingness to use PrEP among Black people in the U.S. South. Ann Epidemiol. 2020 02; 42:33-41.
    View in: PubMed
    Score: 0.143
  13. Understanding the role of resilience resources, antiretroviral therapy initiation, and HIV-1 RNA suppression among people living with HIV in South Africa: a prospective cohort study. AIDS. 2019 06 01; 33 Suppl 1:S71-S79.
    View in: PubMed
    Score: 0.138
  14. Age matters: differences in correlates of self-reported HIV antiretroviral treatment adherence between older and younger Black men who have sex with men living with HIV. AIDS Care. 2019 08; 31(8):965-972.
    View in: PubMed
    Score: 0.137
  15. Internalized HIV stigma, ART initiation and HIV-1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator. J Int AIDS Soc. 2018 10; 21(10):e25198.
    View in: PubMed
    Score: 0.132
  16. African born women living with HIV in the United States: unmet needs and opportunities for intervention. AIDS Care. 2018 12; 30(12):1542-1550.
    View in: PubMed
    Score: 0.130
  17. PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists. AIDS Behav. 2017 May; 21(5):1256-1267.
    View in: PubMed
    Score: 0.119
  18. Qualitative Comparison of Barriers to Antiretroviral Medication Adherence Among Perinatally and Behaviorally HIV-Infected Youth. Qual Health Res. 2017 Jul; 27(8):1177-1189.
    View in: PubMed
    Score: 0.119
  19. Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa. J Acquir Immune Defic Syndr. 2017 04 01; 74(4):432-438.
    View in: PubMed
    Score: 0.119
  20. A Comparison of Home-Based Versus Outreach Event-Based Community HIV Testing in Ugandan Fisherfolk Communities. AIDS Behav. 2017 Feb; 21(2):547-560.
    View in: PubMed
    Score: 0.117
  21. Social Network Characteristics Moderate the Association Between Stigmatizing Attributions About HIV and Non-adherence Among Black Americans Living with HIV: a Longitudinal Assessment. Ann Behav Med. 2015 Dec; 49(6):865-72.
    View in: PubMed
    Score: 0.108
  22. Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV. J Health Psychol. 2016 07; 21(7):1311-21.
    View in: PubMed
    Score: 0.100
  23. Conceptualisations of masculinity and self-reported medication adherence among HIV-positive Latino men in Los Angeles, California, USA. Cult Health Sex. 2014 Jun; 16(6):697-709.
    View in: PubMed
    Score: 0.097
  24. Barriers to care among people living with HIV in South Africa: contrasts between patient and healthcare provider perspectives. AIDS Care. 2013; 25(7):843-53.
    View in: PubMed
    Score: 0.087
  25. Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy. AIDS Patient Care STDS. 2007 Jun; 21(6):390-9.
    View in: PubMed
    Score: 0.060
  26. Patterns and correlates of deliberate abstinence among men and women with HIV/AIDS. Am J Public Health. 2006 Jun; 96(6):1078-84.
    View in: PubMed
    Score: 0.056
  27. Does type of antiretroviral therapy pick-up point influence 12-month virologic suppression in South Africa? AIDS Care. 2024 10; 36(10):1518-1527.
    View in: PubMed
    Score: 0.049
  28. Discrimination and adherence in a cross-sectional study of Latino sexual minority men with HIV: Coping with discrimination as a mediator and coping self-efficacy as a moderator. J Behav Med. 2023 12; 46(6):1057-1067.
    View in: PubMed
    Score: 0.046
  29. Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County. PLoS One. 2022; 17(2):e0262926.
    View in: PubMed
    Score: 0.042
  30. Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South Africa. PLoS One. 2020; 15(9):e0238975.
    View in: PubMed
    Score: 0.038
  31. Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr. 2000 Apr 15; 23(5):396-404.
    View in: PubMed
    Score: 0.037
  32. Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study. J Behav Med. 2008 Oct; 31(5):445-51.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.